Improved stone quality of life in patients with an obstructing ureteral stone on alpha-blocker medical expulsive therapy.

Susan TalaminiDaniel WongTarik PhillipsJoshua PalkaJoel VetterAlexander ChowAlethea ParadisAlana DesaiKenneth SandsCharles NottinghamRamakrishna Venkatesh

Published in: International urology and nephrology (2023)

The use of MET was associated with improved QOL on all WISQOL metrics compared to noMET patients. Improved stone QOL may be an indication of alpha-blocker therapy in patients with ureteral stone colic.

Keyphrases

editorial comment
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
prognostic factors
stem cells
angiotensin converting enzyme
tyrosine kinase
patient reported outcomes
cell therapy
angiotensin ii
smoking cessation